Neodjuvant Chemoimmunotherapy Takes Another Step Forward in Stage IIIA-B NSCLC

Phase II trial supports neoadjuvant nivolumab plus chemotherapy

Related Keywords

Vienna ,Wien ,Austria ,Spain ,Massachusetts ,United States ,Madrid ,Mariano Provencio ,Mike Bassett ,Corinne Faivre Finn ,University Of Manchester ,Hospital Puerta De Hierro ,World Conference ,Lung Cancer ,